During the past decade, Sapporo City General Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 6 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sapporo City General Hospital" #1 sponsor was "Pfizer" with 3 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 2 trials sponsored, "Allergan" with 1 trials sponsored and "Bayer" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sapporo City General Hospital" #1 collaborator was "Tokyo Medical and Dental University" with 2 trials as a collaborator, "Chukyo Hospital" with 1 trials as a collaborator, "Ebina General Hospital" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Hitachi General Hospital" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Sapporo City General Hospital" are "Rheumatoid Arthritis" (4 trials), "Colorectal Cancer" (2 trials), "Age Related Macular Degeneration" (1 trials), "BK Virus Infection" (1 trials) and "Central Neuropathic Pain" (1 trials). Many other conditions were trialed in "Sapporo City General Hospital" in a lesser frequency.

Most popular intervention types in "Sapporo City General Hospital" are "Drug" (17 trials), "Biological" (2 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Sham Procedure" (3 trials), "Faricimab" (2 trials), "UFT adjuvant chemotherapy" (2 trials) and "Abicipar Pegol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sapporo City General Hospital" are 19 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Sapporo City General Hospital". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Sapporo City General Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sapporo City General Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".